GOULASH

The GOULASH trial is a randomized controlled two-arm double-blind multicentre trial. It will provide the first evidence concerning the necessity of early energy supply for patients suffering from acute pancreatitis. Acute pancreatitis (AP) is an inflammatory disease with no specific therapy, however interventional basic research showed that ATP delivery restore the physiological functions of the cells suggesting that restoration of energy level of the pancreas is beneficial.

Patients suffering from acute pancreatitis will be randomly appointed to groups A (30kcal/kg/day energy administration started within 24h of hospital admission) and B (no energy administration in the first 24h of hospital admission).